Nutex Health Inc. (NUTX)
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $204.36
- As of
Kresmion compiles this page from NUTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Nutex Health Inc. (NUTX): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-11.
See the full NUTX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NUTX on one page. Preview it with sample data, then open it live with a free account.
Preview the NUTX dossierActive signals for NUTX
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 89.6%, EPS $9.58 vs $5.0531 estimate
- mediumNEW_POSITION
CITADEL ADVISORS LLC new position in NUTX
- mediumNEW_POSITION
D. E. Shaw & Co., Inc. new position in NUTX
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 598.0% - EPS $7.76 vs $1.1118 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 75.2% - EPS $1.73 vs $6.9768 estimate
FREE, NO ACCOUNT
Every signal on NUTX, as it fires
You are seeing 5 of 6 signals recorded on NUTX since 2026-06-02.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NUTX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 67079U306 · 2026Q2 | $16.7M | 0.01% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 67079U306 · 2026Q2 | $8.9M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 67079U306 · 2026Q2 | $3.1M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NUTX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
NUTX against its peers
NUTX's operating margin of 31.5% ranks in the 97th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | NUTX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 875M USD | 1.4B USD | 36 | 17 |
| Gross margin | 50.8% | n/a | n/a | 4 |
| Operating margin | 31.5% | 2.1% | 97 | 16 |
| Net margin | 8.1% | 1.4% | 92 | 18 |
| Return on equity | 21.5% | 8.3% | 84 | 15 |
| P / E | 19.5x | 28.9x | 35 | 9 |
| 1 year | 100.0% | 14.5% | 83 | 14 |
Peers (18): AGL, ARDT, INNV, SNDA, SGRY, ASTH, ADUS, GRDN, NHC, TOI, MCTA, LFST, CYH, CON, SRTA, FMS, AIRS, JYNT. Left out: LTGHY (no annual filing), GMRS (no annual filing), BUHPY (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing), PARK (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (NUTX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow NUTX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NUTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.